
xCures
AI-powered platform providing real-time healthcare data for treatment decision support and actionable insights.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Convertible | |
Total Funding | 000k |
Related Content
xCures, founded in 2018, operates in the healthcare sector, focusing on leveraging artificial intelligence (AI) to improve patient outcomes. The company provides a platform that extracts, normalizes, and structures real-time healthcare data to support treatment decisions. This platform is particularly beneficial for oncologists and cancer patients, offering rapid and comprehensive access to critical data and actionable insights. xCures primarily serves healthcare providers, researchers, and pharmaceutical companies. The business model revolves around licensing its AI-powered platform to these clients, generating revenue through subscription fees and data analytics services. By addressing the complexities of large-scale cancer patient data and fragmented medical records, xCures aims to transform healthcare data into clinically actionable insights. The company also collaborates with other entities to enhance precision medicine guidelines and support investigational cancer treatments.
Keywords: AI, healthcare, oncology, data analytics, real-time data, treatment support, precision medicine, cancer research, clinical insights, subscription model.